Pharmaceutical giant Novartis has tapped intelligent medicine start-up Proteus Biomedical for a small 20 patient study to track patients’ compliance with their blood pressure drug regimen. The patients are taking blood pressure drug Diovan and the study organizers track their compliance via Proteus’ “chip in the pill” technology, which reports to a receiver sensor on

Originally posted here:
Novartis, Proteus pilot to lead to exclusive deal?

Tags: biomedical, blood, compliance-via, diovan, intelligent, novartis, pill, result, study, taking-blood

This entry was posted on Tuesday, September 22nd, 2009 at 3:45 pm and is filed under Uncategorized, Wireless Life Sciences News . You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.